溫帝國際有限公司
- 主成分
- Orlistat contains NLT 98.0% and NMT101.5% of C29H53NO5, calculated on the anhydrous, solvent free basis.
- 適應症
- 抗肥胖劑
- 主成分
- 適應症
- 限醫療器材管理辦法「一般醫療器械用消毒劑(J.6890)」第一等級鑑別範圍。
- 主成分
- Hyoscine butylbromide content not less than 98.0% and not more than 101.0% of C21H30BrNO4, calculated on the dried basis.
- 適應症
- 副交感神經抑制劑
- 主成分
- Etofenamate content not less than 98.5% and not more than 101.5% of C18H18F3NO4, calculated on the dried basis.
- 適應症
- 抗炎劑
- 主成分
- Tadalafil contains NLT 97.5% and NMT 102.5% of tadalafil (C22H19O4), calculated on the dried basis.
- 適應症
- 治療勃起功能障礙。
- 主成分
- Lysozyme Hydrochloride Activity (on dried basis) ≧ 36.000 Units FIP/mg
- 適應症
- 消炎酵素劑。
- 主成分
- 銀杏抽出物/Ginkgo Dry Extract, Refined and Quantified flavonoids, expressed as flavone glycosides (Mr 756.7):22.0% to 27.0% (dried extract) bilobalide:2.6% to 3.2% (dried extract) ginkgolides A, B and C:2.8% to 3.4% (dried extract) ginkgolic acids:maximum 5 ppm (dried extract)
- 適應症
- 末梢血管循環障礙。
- 主成分
- Levocetirizine Dihydrochloride contains NLT 98.0% and NMT 102.0% of Levocetirizine Dihydrochloride (C21H25ClN2O3‧2HCl), calculated on the dried basis.
- 適應症
- 抗過敏製劑
- 主成分
- Carbimazole C7H10N2O2S 186.2 Ethyl 3-methyl-2-thioxo-2, 3-dihydro-1H-imidazole-1-carboxylate. Content:98.0 percent to 102.0 percent (dried substance).
- 適應症
- 抗甲狀腺劑
- 主成分
- Betamethasone sodium Phosphate content not less than 96.0% and not more than 103.0% of C22H28FNa2O8P, calculated on the anhydrous basis.
- 適應症
- 抗炎性皮質醇
- 主成分
- Deoxycholic Acid contains not less than 97.0% and not more than 103.0% of C24H40O4, calculated on the anhydrous basis.
- 適應症
- 乳化劑;頦下脂肪消除劑(注射)
- 主成分
- Methyltestosterone contains NLT 97.0% and NMT 103.0% of methyltestosterone (C20H30O2), calculated on the dried basis.
- 適應症
- 雄性激素。
- 主成分
- Minocycline Hydrochloride Dihydrate contains not less than 94.5% and not more than 102.0% of C23H28CIN3O7‧2H2O, calculated on the anhydrous substance.
- 適應症
- 抗生素
- 主成分
- Betamethasone Dipropionate contains not less than 97.0% and not more than 103.0% of C28H37FO7, calculated on the dried basis.
- 適應症
- 抗炎性皮質醇
- 主成分
- Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C28H38N6O11S, calculated on the anhydrous substance.
- 適應症
- 男性勃起障礙治療
- 主成分
- Calcitriol contains not less than 97.0% and not more than 103.0% of C27H44O3
- 適應症
- 維他命D3缺乏症
- 主成分
- Tadalafil contains not less than 97.5% and not more than 102.0% of C22H19N3O4, calculated on the dried substance.
- 適應症
- 男性勃起障礙治療
- 主成分
- Betamethasone Valerate contains not less than 97.0 percent and not more than 103.0 percent of C27H37FO6, calculated on the dried basis.
- 適應症
- 抗炎性皮質醇(外用)